
Agrichemicals firm FMC posted a nearly 50% drop in Q3 net sales on Wednesday, weighed down by divestiture of India business and pricing changes
Shares of FMC FMC.N fall nearly 4% in premarket trading
At least seven brokerages cut PT after co reported downbeat annual profit forecast
Nine of 21 brokerages rate the stock "buy" or higher, 11 "hold" and one "strong sell"; their median PT is $39.5 - data compiled by LSEG
As of last close, shares down about 68% YTD
PRICING PRESSURES MOVING FORWARD
Jefferies (cuts PT to $26 from $49) says the diamide contract headwinds and the Latin American generic pricing pressures likely hinder sales again in Q4
Barclays ("equal-weight", cuts PT to $22 from $48) says co to be hurt by pricing headwinds from generics and cost-plus adjustments in Q4
KeyBanc ("sector weight") says while there is path to upside, 2026 will present additional cash pressures as FMC needs to lower cost of production